🕵️ Capricor Therapeutics, Inc. ($CAPR)
SEC insider & ownership activity, last 12 months · CIK 1133869 · every row links its SEC filing
Over the last 12 months insiders sold $8.4M with no open-market buying against it. Karimah Es Sabar sold $3.8M through a 10b5-1 trading plan in 3 lots (Mar–Apr). 1 planned sale is pending, the largest $273K (David B. Musket). No red-flag 8-Ks in the window.
🚨 1 signal active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $8.4M (13 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Karimah Es Sabar | 0 | – | 3 | $3.8M | Apr 2, 2026 |
| Bergmann Anthony | 0 | – | 5 | $2.3M | Jun 25, 2026 |
| Krasney Karen | 0 | – | 5 | $2.3M | Jun 25, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| TANG Capital Management, LLC | 6.6% | 13G | Jan 26, 2026 | filing ↗ | |
| Kevin Tang | 6.6% | 13G | Jan 26, 2026 | filing ↗ | |
| Suvretta Capital Management, LLC | 6.6% | 13G | Feb 26, 2026 | filing ↗ | |
| Aaron Cowen | 6.6% | 13G | Feb 26, 2026 | filing ↗ | |
| Blackrock, Inc. | 6.5% | 13G | Feb 5, 2025 | filing ↗ | |
| Averill Master Fund, Ltd. | 5.6% | 13G | Feb 26, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| David B. Musket | $273K | May 19, 2026 | filing ↗ |
| Karimah Es Sabar | $227K | Apr 2, 2026 | filing ↗ |
| Karen Krasney | $2.1M | Mar 31, 2026 | filing ↗ |
| Anthony Bergmann | $2.1M | Mar 31, 2026 | filing ↗ |
| Karimah Es Sabar | $3.2M | Mar 31, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 29, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 9, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 9, 2026 | filing ↗ |
| Other events (8.01) | Jun 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 26, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 7, 2026 | filing ↗ |
| Other events (8.01) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 10, 2026 | filing ↗ |
| Other events (8.01) | Mar 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 5, 2025 | filing ↗ |
| Other events (8.01) | Dec 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 5, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 3, 2025 | filing ↗ |
| Other events (8.01) | Dec 3, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 3, 2025 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Earnings (2.02) | Aug 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2025 | filing ↗ |